Clin Endosc.  2021 Jul;54(4):578-588. 10.5946/ce.2020.198.

Clinical Features and Predictors of Dysplasia in Proximal Sessile Serrated Lesions

Affiliations
  • 1Department of Gastroenterology and Hepatology, Changi General Hospital, Singapore, Singapore
  • 2Department of Pathology, Changi General Hospital, Singapore, Singapore
  • 3Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
  • 4Pathology Academic Clinical Programme, SingHealth Duke-NUS Medical School, Singapore, Singapore

Abstract

Background/Aims
Proximal colorectal cancers (CRCs) account for up to half of CRCs. Sessile serrated lesions (SSLs) are precursors to CRC. Proximal location and presence of dysplasia in SSLs predict higher risks of progression to cancer. The prevalence of dysplasia in proximal SSLs (pSSLs) and clinical characteristics of dysplastic pSSLs are not well studied.
Methods
Endoscopically resected colonic polyps at our center between January 2016 and December 2017 were screened for pSSLs. Data of patients with at least one pSSL were retrieved and clinicopathological features of pSSLs were analysed. pSSLs with and without dysplasia were compared for associations.
Results
Ninety pSSLs were identified, 45 of which had dysplasia giving a prevalence of 50.0%. Older age (65.9 years vs. 60.1 years, p=0.034) was associated with the presence of dysplasia. Twelve pSSLs were 10 mm or larger. After adjusting for age, pSSLs ≥10 mm had an adjusted odds ratio of 5.98 (95% confidence interval, 1.21–29.6) of having dysplasia compared with smaller pSSLs.
Conclusions
In our cohort of pSSLs, the prevalence of dysplasia is high at 50.0% and is associated with lesion size ≥10 mm. Endoscopic resection for all proximal serrated lesions should be en-bloc to facilitate accurate histopathological examination for dysplasia as its presence warrants shorter surveillance intervals.

Keyword

Dysplasia; Large; Prevalence; Proximal; Sessile serrated lesion

Figure

  • Fig. 1. Proximal sessile serrated lesion without dysplasia. White light (A) and narrow band imaging (NBI) (B) views of a proximal sessile serrated lesion without dys Paris type 0-IIa lesion covered with a mucous cap. On NBI, the lesion has a similar colour to the back without brown vessels, findings consistent with type 1 neoplasm on narrow-band imaging international colorectal endoscopic classification.

  • Fig. 2. Proximal sessile serrated lesion with dysplasia. White light (A) and narrow band imaging (NBI) (B) views of a proximal sessile serrated lesion with dysplasia. Paris Type Is lesion with a nodular surface predictive of cytological dysplasia. On NBI, the lesion appears brown, with visible brown vessels and tubular branched white structures, findings consistent with type 2 neoplasm on narrow-band imaging international colorectal endoscopic (NICE) classification. Typically, NICE-2 lesions predict a histology of tubular adenoma with dysplasia.

  • Fig. 3. Proximal sessile serrated lesion without dysplasia. (A) Hematoxylin and eosin stained section of a 5-mm proximal sessile serrated lesion without dysplasia removed by snare polypectomy. (B, C) Low and mepower microscopic views highlighting the prominent serration with extension down to the basal crypt region and the unequivocal basal crypt dilation (×40, ×100 magnification).

  • Fig. 4. Proximal sessile serrated lesion with dysplasia. (A) Hematoxylin and eosin stained section of a 20-mm proximal sessile serrated lesion with dysplasia resected en bloc by endoscopic submucosal dissection. (B, C) Low and medium power microscopic views of the dysplasia resembling conventional adenoma type within the sessile serrated lesion that is defined by the charserration down to the basal crypt region with the dilation and horizontalization of the basal crypts along the muscularis mucosae (×40, ×100 magnification).

  • Fig. 5. Various endoscopic photos of small proximal sessile serrated lesions (≤5 mm) with dysplasia.

  • Fig. 6. Histopathology of a proximal sessile serrated lesion with dysplasia. (A) Hematoxylin and eosin stained section (×20) of a 5-mm proximal sessile serrated lesion with dysplasia. (B) Higher magnification of the dysplastic focus within the pSSL (×200) characterized by nuclear enlargement, hyperchromasia and pseudo stratification, changes in chromatin pattern and mitoses. pSSLs, proximal sessile serrated lesion.

  • Fig. 7. Histopathology of a proximal sessile serrated lesion with dysplasia. (A) Hematoxylin and eosin stained section of a proximal sessile serrated lesion with dysplasia removed in piecemeal. (B) Medium power view of the dysplascomponent identified in a superficial fragment (×100 magnification). (C-E) Fragments containing the characteristic histological features of sessile serrated lesion serration and basal crypt changes. Cautery artefact is present (×100 magnification).


Cited by  2 articles

Korean guidelines for postpolypectomy colonoscopic surveillance: 2022 revised edition
Su Young Kim, Min Seob Kwak, Soon Man Yoon, Yunho Jung, Jong Wook Kim, Sun-Jin Boo, Eun Hye Oh, Seong Ran Jeon, Seung-Joo Nam, Seon-Young Park, Soo-Kyung Park, Jaeyoung Chun, Dong Hoon Baek, Mi-Young Choi, Suyeon Park, Jeong-Sik Byeon, Hyung Kil Kim, Joo Young Cho, Moon Sung Lee, Oh Young Lee
Clin Endosc. 2022;55(6):703-725.    doi: 10.5946/ce.2022.136.

Korean Guidelines for Postpolypectomy Colonoscopic Surveillance: 2022 revised edition
Su Young Kim, Min Seob Kwak, Soon Man Yoon, Yunho Jung, Jong Wook Kim, Sun-Jin Boo, Eun Hye Oh, Seong Ran Jeon, Seung-Joo Nam, Seon-Young Park, Soo-Kyung Park, Jaeyoung Chun, Dong Hoon Baek, Mi-Young Choi, Suyeon Park, Jeong-Sik Byeon, Hyung Kil Kim, Joo Young Cho, Moon Sung Lee, Oh Young Lee
Intest Res. 2023;21(1):20-42.    doi: 10.5217/ir.2022.00096.


Reference

1. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer. 1975; 36:2251–2270.
Article
2. Boparai KS, Dekker E, Polak MM, Musler AR, van Eeden S, van Noesel CJ. A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome. Am J Pathol. 2011; 178:2700–2707.
Article
3. Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology. 2010; 138:2088–2100.
Article
4. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007; 50:113–130.
Article
5. Bettington M, Walker N, Clouston A, Brown I, Leggett B, Whitehall V. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology. 2013; 62:367–386.
Article
6. Gomez D, Dalal Z, Raw E, Roberts C, Lyndon PJ. Anatomical distribution of colorectal cancer over a 10 year period in a district general hospital: is there a true “rightward shift”? Postgrad Med J. 2004; 80:667–669.
Article
7. Baber J, Anusionwu C, Nanavaty N, Agrawal S. Anatomical distribution of colorectal cancer in a Veterans Affairs Medical Center. South Med J. 2014; 107:443–447.
Article
8. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020; 70:7–30.
Article
9. Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019; 394:1467–1480.
Article
10. Missiaglia E, Jacobs B, D’Ario G, et al. Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features. Ann Oncol. 2014; 25:1995–2001.
Article
11. Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019; 16:713–732.
Article
12. Anderson JC. Pathogenesis and management of serrated polyps: current status and future directions. Gut Liver. 2014; 8:582–589.
Article
13. Kahi CJ, Hewett DG, Norton DL, Eckert GJ, Rex DK. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol. 2011; 9:42–46.
Article
14. JE IJ, de Wit K, van der Vlugt M, Bastiaansen BA, Fockens P, Dekker E. Prevalence, distribution and risk of sessile serrated adenomas/polyps at a center with a high adenoma detection rate and experienced pathologists. Endoscopy. 2016; 48:740–746.
Article
15. Erichsen R, Baron JA, Hamilton-Dutoit SJ, et al. Increased risk of colorectal cancer development among patients with serrated polyps. Gastroenterology. 2016; 150:895–902.e5.
Article
16. Bettington M, Walker N, Rosty C, et al. Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma. Gut. 2017; 66:97–106.
Article
17. Holme Ø, Bretthauer M, Eide TJ, et al. Long-term risk of colorectal cancer in individuals with serrated polyps. Gut. 2015; 64:929–936.
Article
18. IJspeert JEG, Bevan R, Senore C, et al. Detection rate of serrated polyps and serrated polyposis syndrome in colorectal cancer screening cohorts: a European overview. Gut. 2017; 66:1225–1232.
Article
19. Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol. 2011; 42:1–10.
Article
20. Burgess NG, Tutticci NJ, Pellise M, Bourke MJ. Sessile serrated adenomas/polyps with cytologic dysplasia: a triple threat for interval cancer. Gastrointest Endosc. 2014; 80:307–310.
Article
21. Liu C, Walker NI, Leggett BA, Whitehall VL, Bettington ML, Rosty C. Sessile serrated adenomas with dysplasia: morphological patterns and correlations with MLH1 immunohistochemistry. Mod Pathol. 2017; 30:1728–1738.
Article
22. Yang JF, Tang SJ, Lash RH, Wu R, Yang Q. Anatomic distribution of sessile serrated adenoma/polyp with and without cytologic dysplasia. Arch Pathol Lab Med. 2015; 139:388–393.
Article
23. Abdeljawad K, Vemulapalli KC, Kahi CJ, Cummings OW, Snover DC, Rex DK. Sessile serrated polyp prevalence determined by a colonoscopist with a high lesion detection rate and an experienced pathologist. Gastrointest Endosc. 2015; 81:517–524.
Article
24. Bouwens MW, van Herwaarden YJ, Winkens B, et al. Endoscopic characterization of sessile serrated adenomas/polyps with and without dysplasia. Endoscopy. 2014; 46:225–235.
Article
25. Hazewinkel Y, de Wijkerslooth TR, Stoop EM, et al. Prevalence of serrated polyps and association with synchronous advanced neoplasia in screening colonoscopy. Endoscopy. 2014; 46:219–224.
Article
26. Lash RH, Genta RM, Schuler CM. Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol. 2010; 63:681–686.
Article
27. Sheridan TB, Fenton H, Lewin MR, et al. Sessile serrated adenomas with low- and high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions “caught in the act”. Am J Clin Pathol. 2006; 126:564–571.
28. Armaghany T, Wilson JD, Chu Q, Mills G. Genetic alterations in colorectal cancer. Gastrointest Cancer Res. 2012; 5:19–27.
29. Pan J, Xin L, Ma YF, Hu LH, Li ZS. Colonoscopy reduces colorectal cancer incidence and mortality in patients with non-malignant findings: a meta-analysis. Am J Gastroenterol. 2016; 111:355–365.
Article
30. Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013; 369:1095–1105.
Article
31. JE IJ, Vermeulen L, Meijer GA, Dekker E. Serrated neoplasia-role in colorectal carcinogenesis and clinical implications. Nat Rev Gastroenterol Hepatol. 2015; 12:401–409.
Article
32. Anderson JC, Butterly LF, Weiss JE, Robinson CM. Providing data for serrated polyp detection rate benchmarks: an analysis of the New Hampshire Colonoscopy Registry. Gastrointest Endosc. 2017; 85:1188–1194.
Article
33. Sarvepalli S, Garber A, Rothberg MB, et al. Association of adenoma and proximal sessile serrated polyp detection rates with endoscopist characteristics. JAMA Surg. 2019; 154:627–635.
Article
34. Murakami T, Sakamoto N, Ritsuno H, et al. Distinct endoscopic characteristics of sessile serrated adenoma/polyp with and without dysplasia/carcinoma. Gastrointest Endosc. 2017; 85:590–600.
Article
35. Sano W, Fujimori T, Ichikawa K, et al. Clinical and endoscopic evaluations of sessile serrated adenoma/polyps with cytological dysplasia. J Gastroenterol Hepatol. 2018; 33:1454–1460.
Article
36. Rustagi T, Rangasamy P, Myers M, et al. Sessile serrated adenomas in the proximal colon are likely to be flat, large and occur in smokers. World J Gastroenterol. 2013; 19:5271–5277.
Article
37. WHO classification of tumours. Digestive System Tumours. 5th ed. Lyon: International Agency for Research on Cancer;2019. Chapter: Colorectal serrated lesions and polyps. p. 165–167.
38. Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med. 1990; 113:779–788.
Article
39. Rutter MD, East J, Rees CJ, et al. British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines. Gut. 2020; 69:201–223.
Article
40. Gupta S, Lieberman D, Anderson JC, et al. Recommendations for follow-up after colonoscopy and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2020; 91:463–485.e5.
Article
41. Kim KH, Kim KO, Jung Y, et al. Clinical and endoscopic characteristics of sessile serrated adenomas/polyps with dysplasia/adenocarcinoma in a Korean population: a Korean Association for the Study of Intestinal Diseases (KASID) multicenter study. Sci Rep. 2019; 9:3946.
Article
42. Burgess NG, Pellise M, Nanda KS, et al. Clinical and endoscopic predictors of cytological dysplasia or cancer in a prospective multicentre study of large sessile serrated adenomas/polyps. Gut. 2016; 65:437–446.
Article
43. Yan HHN, Lai JCW, Ho SL, et al. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation. Gut. 2017; 66:1645–1656.
Article
44. Nguyen LH, Goel A, Chung DC. Pathways of colorectal carcinogenesis. Gastroenterology. 2020; 158:291–302.
Article
45. He X, Hang D, Wu K, et al. Long-term risk of colorectal cancer after removal of conventional adenomas and serrated polyps. Gastroenterology. 2020; 158:852–861.e4.
Article
46. Kaltenbach T, Anderson JC, Burke CA, et al. Endoscopic removal of colorectal lesions-recommendations by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2020; 158:1095–1129.
Article
47. Davenport JR, Su T, Zhao Z, et al. Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps. Gut. 2018; 67:456–465.
Article
48. Ng SC, Ching JY, Chan VC, et al. Association between serrated polyps and the risk of synchronous advanced colorectal neoplasia in average-risk individuals. Aliment Pharmacol Ther. 2015; 41:108–115.
Article
49. Liang PS, Chen TY, Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer. 2009; 124:2406–2415.
Article
50. Carr PR, Alwers E, Bienert S, et al. Lifestyle factors and risk of sporadic colorectal cancer by microsatellite instability status: a systematic review and meta-analyses. Ann Oncol. 2018; 29:825–834.
Article
51. Limsui D, Vierkant RA, Tillmans LS, et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst. 2010; 102:1012–1022.
Article
Full Text Links
  • CE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr